Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hutchinson Centre Research Institute most commonly refers not to a standalone commercial biotech company, but to nonprofit Fred Hutch-affiliated legal entities in Africa, principally Hutchinson Centre Research Institute of South Africa and Hutchinson Centre Research Institute of Uganda. These entities support clinical, laboratory and translational research in HIV, tuberculosis, infectious diseases and infection-related cancers, and provide local infrastructure for Fred Hutch global health and oncology collaborations. In South Africa, the organization includes the Cape Town HVTN Immunology Laboratory, which supports HIV Vaccine Trials Network studies and immune-response testing for candidate HIV and tuberculosis vaccines. In Uganda, the entity supports the UCI-Fred Hutch Collaboration and related cancer and infectious-disease research with the Uganda Cancer Institute. Because the user-provided name omits the country qualifier, the requested name is ambiguous across at least two active Fred Hutch subsidiaries rather than an exact single-company match.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hutchinson Centre Research Institute.